Cambridge MedTech spinout acquired by France-based SeqOne

AI-driven genomic analysis firm SeqOne has agreed a deal to acquire Congenica, a Cambridge-based company spun out of the prestigious Wellcome Sanger Institute, for an undisclosed amount.

The acquisition ‘creates the largest global software pure player in the genomics space’, serving over 160 labs in more than 30 countries.

Founded in 2012, Congenica services over 25 private and public labs, including multiple NHS Genomics Laboratory Hubs and prestigious national programs such as Genomics England and the Hong Kong Genomic Program.

Read the full article.